|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 94.60 USD | +1.46% |
|
+7.69% | -24.51% |
| Jun. 25 | Major deals involving US drugmakers and biotechs over the past decade | RE |
| Jun. 24 | Abbott Laboratories, ALZpath Sign Global Licensing Deal for Alzheimer's Disease Diagnostic | MT |
| Market Cap | 162B 143B 131B 123B 230B 15,325B 235B 1,577B 611B 7,554B 610B 597B 26,252B | P/E 2026 * |
23.4x | P/E 2027 * | 20.1x |
|---|---|---|---|---|---|
| Enterprise Value | 174B 153B 141B 132B 247B 16,431B 252B 1,691B 655B 8,100B 654B 640B 28,148B | EV / Sales 2026 * |
3.46x | EV / Sales 2027 * | 3.13x |
| Free-Float |
86.73% | Yield 2026 * |
2.73% | Yield 2027 * | 2.91% |
Last Transcript: Abbott Laboratories
| 1 day | +1.55% | ||
| 1 week | +8.06% | ||
| Current month | +10.88% | ||
| 1 month | +9.51% | ||
| 3 months | -9.24% | ||
| 6 months | -23.97% | ||
| Current year | -24.25% |
| 1 week | 87.21 |  | 95.21 |
| 1 month | 84.96 | | 95.21 |
| Current year | 81.97 | | 129.46 |
| 1 year | 81.97 | | 137.49 |
| 3 years | 81.97 | | 141.23 |
| 5 years | 81.97 | | 142.6 |
| 10 years | 36.76 | | 142.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Ford
CEO | Chief Executive Officer | 52 | 2020-03-30 |
Philip Boudreau
DFI | Director of Finance/CFO | 53 | 2023-08-31 |
Sabina Ewing
CIO | Chief Investment Officer | 51 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Sally Blount
BRD | Director/Board Member | 64 | 2011-12-08 |
Nancy McKinstry
BRD | Director/Board Member | 67 | 2011-12-08 |
Daniel Starks
BRD | Director/Board Member | 71 | 2017-02-15 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Apr. 27 | Other | Head of Human Resources | 5,314 | 0.0003% | ||
| Apr. 23 | Free | Director | 2,286 | 0.0001% | ||
| Apr. 23 | Other | Director | 131,451 | 0.0076% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.45% | +8.06% | -29.00% | -12.53% | 162B | |
| +1.84% | +3.03% | -5.23% | -6.13% | 103B | |
| +0.86% | +6.99% | -2.18% | +54.51% | 55.83B | |
| -2.09% | -10.31% | +49.00% | +52.19% | 54.05B | |
| +2.59% | +10.94% | -8.16% | -39.14% | 41.71B | |
| +3.12% | +11.44% | - | - | 31.94B | |
| +1.51% | +1.37% | -17.67% | -43.82% | 26.49B | |
| -0.78% | +4.99% | +58.06% | -5.18% | 24.48B | |
| +2.12% | +7.56% | -9.63% | +1.68% | 20.52B | |
| +0.84% | -2.08% | -17.51% | -3.19% | 20.02B | |
| Average | +1.21% | +1.24% | +1.96% | -0.18% | 54.05B | |
| Weighted average by Cap. | +1.29% | +2.07% | -5.22% | +0.49% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 50.29B 44.17B 40.7B 38.06B 71.37B 4,745B 72.68B 488B 189B 2,339B 189B 185B 8,129B | 54.79B 48.13B 44.34B 41.46B 77.76B 5,170B 79.19B 532B 206B 2,549B 206B 201B 8,857B |
| Net income | 7.02B 6.17B 5.68B 5.31B 9.96B 662B 10.14B 68.15B 26.4B 326B 26.36B 25.78B 1,135B | 8.39B 7.37B 6.79B 6.35B 11.91B 792B 12.13B 81.49B 31.56B 390B 31.52B 30.82B 1,357B |
| Net Debt | 11.73B 10.3B 9.49B 8.87B 16.64B 1,107B 16.95B 114B 44.1B 545B 44.04B 43.07B 1,896B | 8.88B 7.8B 7.19B 6.72B 12.61B 838B 12.84B 86.26B 33.41B 413B 33.36B 32.63B 1,436B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | $94.58 | +1.44% | 3,186,590 |
| 26-06-25 | $93.24 | +3.04% | 16,708,691 |
| 26-06-24 | $90.49 | -0.04% | 13,201,602 |
| 26-06-23 | $90.53 | +3.07% | 12,201,914 |
| 26-06-22 | $87.83 | -0.66% | 11,458,235 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ABT Stock
Select your edition
All financial news and data tailored to specific country editions
